rezvoglar kwikpen

Generic: insulin glargine-aglr

Labeler: eli lilly and company
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name rezvoglar kwikpen
Generic Name insulin glargine-aglr
Labeler eli lilly and company
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

insulin glargine 100 [iU]/mL

Manufacturer
Eli Lilly and Company

Identifiers & Regulatory

Product NDC 0002-8980
Product ID 0002-8980_a9e95b4c-e280-4bef-a3dd-4907bfad6b4d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761215
Listing Expiration 2026-12-31
Marketing Start 2021-12-17

Pharmacologic Class

Established (EPC)
insulin analog [epc]
Chemical Structure
insulin [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00028980
Hyphenated Format 0002-8980

Supplemental Identifiers

RxCUI
2589008 2589014
UNII
2ZM8CX04RZ
NUI
M0011417 N0000175453

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rezvoglar kwikpen (source: ndc)
Generic Name insulin glargine-aglr (source: ndc)
Application Number BLA761215 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 100 [iU]/mL
source: ndc
Packaging
  • 5 SYRINGE in 1 CARTON (0002-8980-05) / 3 mL in 1 SYRINGE (0002-8980-01)
source: ndc

Packages (1)

0002-8980-05 5 SYRINGE in 1 CARTON (0002-8980-05) / 3 mL in 1 SYRINGE (0002-8980-01)

Ingredients (1)

insulin glargine (100 [iU]/mL)

Linked Drug Pages (1)

Rezvoglar KwikPen ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "a9e95b4c-e280-4bef-a3dd-4907bfad6b4d", "openfda": {"nui": ["M0011417", "N0000175453"], "unii": ["2ZM8CX04RZ"], "rxcui": ["2589008", "2589014"], "spl_set_id": ["f6af8706-2058-4fe1-99c8-43684c20bfa2"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 SYRINGE in 1 CARTON (0002-8980-05)  / 3 mL in 1 SYRINGE (0002-8980-01)", "package_ndc": "0002-8980-05", "marketing_start_date": "20211217"}], "brand_name": "Rezvoglar KwikPen", "product_id": "0002-8980_a9e95b4c-e280-4bef-a3dd-4907bfad6b4d", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Insulin Analog [EPC]", "Insulin [CS]"], "product_ndc": "0002-8980", "generic_name": "Insulin glargine-aglr", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rezvoglar", "brand_name_suffix": "KwikPen", "active_ingredients": [{"name": "INSULIN GLARGINE", "strength": "100 [iU]/mL"}], "application_number": "BLA761215", "marketing_category": "BLA", "marketing_start_date": "20211217", "listing_expiration_date": "20261231"}